Filing Details
- Accession Number:
- 0001246360-12-002852
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-27 17:25:10
- Reporting Period:
- 2012-06-25
- Filing Date:
- 2012-06-27
- Accepted Time:
- 2012-06-27 17:25:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 911326 | Synageva Biopharma Corp | GEVA | Biological Products, (No Disgnostic Substances) (2836) | 561808663 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532219 | Anthony Quinn | 128 Spring Street, Suite 520 Lexington MA 02421 | Svp, Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-06-25 | 26,000 | $40.65 | 20,035 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 24, 2012.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $40.00 to $40.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Billionaire Hedge Funds
